Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Eagle Pharmaceuticals Inc (EGRX)
OTHER OTC:EGRX
RESEARCH TOOLSreports
Holding EGRX?
Track your performance easily
EGRX Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range<$0.01 - $6.81
Previous Close$0.55
Volume11.09K
Average Volume (3M)163.29K
Market Cap
$7.79M
Enterprise Value$62.63M
Total Cash (Recent Filing)$15.35M
Total Debt (Recent Filing)$70.19M
Price to Earnings (P/E)0.6
Beta2.18
Next Earnings
Nov 04, 2024EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.91
Shares Outstanding12,986,971
10 Day Avg. Volume17,897
30 Day Avg. Volume163,289
Standard Deviation0.19
R-Squared0.04
Alpha-0.05
Financial Highlights & Ratios
Price to Book (P/B)0.03
Price to Sales (P/S)0.03
Price to Cash Flow (P/CF)-15.50
P/FCF Ratio2.90
Enterprise Value/Market CapN/A
Enterprise Value/Revenue0.24
Enterprise Value/Gross Profit0.28
Enterprise Value/Ebitda1.10
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Eagle Pharmaceuticals News
PremiumCompany Announcements
Eagle Pharmaceuticals Appoints New CFO Amid Leadership Change
PremiumCompany Announcements
Eagle Pharmaceuticals Implements Stockholder Rights Plan
PremiumCompany Announcements
Eagle Pharmaceuticals Navigates Financial Uncertainty and Defaults
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
EGRX FAQ
What was Eagle Pharmaceuticals Inc’s price range in the past 12 months?
Eagle Pharmaceuticals Inc lowest stock price was <$0.01 and its highest was $6.81 in the past 12 months.
What is Eagle Pharmaceuticals Inc’s market cap?
Currently, no data Available
When is Eagle Pharmaceuticals Inc’s upcoming earnings report date?
Eagle Pharmaceuticals Inc’s upcoming earnings report date is Nov 04, 2024 which is 48 days ago.
How were Eagle Pharmaceuticals Inc’s earnings last quarter?
Currently, no data Available
Is Eagle Pharmaceuticals Inc overvalued?
According to Wall Street analysts Eagle Pharmaceuticals Inc’s price is currently Overvalued.
Does Eagle Pharmaceuticals Inc pay dividends?
Eagle Pharmaceuticals Inc does not currently pay dividends.
What is Eagle Pharmaceuticals Inc’s EPS estimate?
Eagle Pharmaceuticals Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Eagle Pharmaceuticals Inc have?
Eagle Pharmaceuticals Inc has 12,986,971 shares outstanding.
What happened to Eagle Pharmaceuticals Inc’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Eagle Pharmaceuticals Inc?
Among the largest hedge funds holding Eagle Pharmaceuticals Inc’s share is Royce & Associates LLC. It holds Eagle Pharmaceuticals Inc’s shares valued at 52K.
---
Eagle Pharmaceuticals Stock Smart Score
Company Description
Eagle Pharmaceuticals Inc
Eagle Pharmaceuticals, Inc. engages in the provision of injectable products. Its products include argatroban, ryanodex, docetaxel injection, non-alcohol formulation and bendeka. The company was founded by Scott L. Tarriff on January 2, 2007 and is headquartered in Woodcliff Lake, NJ.
---
EGRX Earnings Call
Q2 2023
0:00 / 0:00
---
Technical Analysis
---